OXUR

Actualités Oxurion NV

Les meilleurs offres pour accéder les cours en temps réel en illimité
Intégral
Abonnement Mensuel
Seulement
19,79 €
Mini
Abonnement Mensuel
Seulement
10,55 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Oxurion NV OXUR Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,024 -5,38% 0,422 17:40:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,44 0,42 0,444 0,422 0,446
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/6/202220:00GLOBEInformation on the Total Number of Voting Rights..
13/6/202219:00GLOBEOxurion Announces Two Presentations at The Macula Society..
07/6/202219:00GLOBEOxurion Announces Preclinical Presentation on THR-149 at..
03/6/202208:00GLOBEOxurion Announces Two Upcoming Presentations at The Macula..
01/6/202219:15GLOBEOxurion to Participate in Upcoming Investor Conferences
31/5/202219:00GLOBEInformation on the Total Number of Voting Rights..
25/5/202219:00GLOBEOxurion Announces Results of the Extraordinary Shareholders’..
24/5/202219:00GLOBEOxurion Announces Upcoming Preclinical Presentation on ..
09/5/202208:30GLOBEOxurion Announces Top-Line Results from Part A of Phase 2..
11/4/202207:00GLOBEOxurion Announces Upcoming Pre-Clinical Data Presentation on..
01/4/202219:00GLOBEOxurion Announces Extraordinary and Annual Shareholders’..
30/3/202219:00GLOBEInformation on the Total Number of Voting Rights..
28/3/202208:00GLOBEOxurion to Participate in Needham Virtual Healthcare..
25/3/202222:11GLOBEOxurion Publishes 2021 Annual Report
17/3/202219:00GLOBEOxurion Receives Transparency Notifications from Fidelity..
07/3/202210:00GLOBEOxurion Successfully Closes EUR >10 Million in Private..
03/3/202212:15GLOBEOXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US..
03/3/202208:00GLOBEOXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US..
22/2/202208:01GLOBEInformation on the Total Number of Voting Rights..
22/2/202208:00GLOBEOxurion NV announces 2021 Full Year Results and 2022 Outlook
14/2/202208:00GLOBEOxurion Announces New Data on THR-149 Phase 2 Clinical Trial..
11/2/202208:00GLOBEOxurion Announces Upcoming Presentation on THR-149 Phase 2..
08/2/202208:00GLOBEOxurion to Participate in the 2022 BIO CEO and Investor..
18/1/202208:00GLOBEOXURION to Participate in the 10th edition of Degroof..
07/1/202207:00GLOBEOxurion Provides Update on Clinical Pipeline Progress
04/1/202218:00GLOBEOXURION to Present at the H.C. Wainwright BioConnect 2022..
30/11/202107:00GLOBEInformation on the Total Number of Voting Rights..
24/11/202107:30GLOBEOXURION to Present at the Ophthalmology Day at BTIG
22/11/202107:00GLOBEOXURION NV Secures EUR 10 Million Convertible Bond Financing..
15/11/202107:00GLOBEOXURION NV - First Patient Dosed in Part B of Phase 2..
04/11/202107:00GLOBEOxurion NV Announces Initiation of Equity Analyst Coverage..
13/10/202107:00GLOBEOxurion NV Announces First Patient Dosed in its Phase 2..
11/10/202107:00GLOBEOXURION - Positive Phase 2 Part A THR-149 data shared at the..
05/10/202108:00GLOBEOXURION to Present at the Lytham Partners Fall 2021 Investor..
30/9/202107:00GLOBEOXURION Announces Positive Results from Part A of Phase 2..
09/9/202119:00GLOBEOxurion NV Business & Financial Update – H1 2021
17/8/202108:00GLOBEOxurion NV - Publication of Positive Phase 1 Clinical Data..
16/8/202108:00GLOBEOxurion NV - Journal of Pharmacokinetics and..
05/8/202117:45GLOBEOXURION to Participate in Upcoming Investor Meetings
Dernières Valeurs Consultées
EU
OXUR
Oxurion NV
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20220703 09:30:30